ERIS Lifesciences Ltd Nine Monthly Results

Gross Sales

1,444.03

1,265.22

1,025.07

918.39

814.1

Excise Duty

0

0

0

0

0

Net Sales

1,444.03

1,265.22

1,025.07

918.39

814.1

Other Operating Income

14.19

17.13

16.03

15.27

11.4

Other Income

8.67

10.15

18.03

6.5

16.46

Total Income

1,466.89

1,292.5

1,059.13

940.15

841.96

Total Expenditure

931.82

864.5

653.04

597.6

534.35

PBIDT

535.07

428

406.09

342.55

307.6

Interest

51.77

17.3

2.89

1.26

1.81

PBDT

483.3

410.7

403.2

341.3

305.79

Depreciation

128.7

81.96

46.34

31.53

35.94

Minority Interest Before NP

0

0

0

0

0

Tax

66.49

57.66

74.45

56.36

49.21

Deferred Tax

-29.32

-41.6

-43.41

-33.48

-19.59

Reported Profit After Tax

317.42

312.68

325.82

286.89

240.24

Minority Interest After NP

-3.6

-4.06

0

0

0.01

Net Profit after Minority Interest

321.02

316.74

325.82

286.89

240.23

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

321.02

316.74

325.82

286.89

240.23

EPS (Unit Curr.)

23.6

23.29

23.98

21.13

17.47

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

13.6

13.6

13.59

13.58

13.75

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

37.05

33.82

39.61

37.29

37.78

PBDTM(%)

33.46

32.46

39.33

37.16

37.56

PATM(%)

21.98

24.71

31.78

31.23

29.5